JOHN JERNIGAN: Open Payments
NPI 1881635480 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,034 in 84 payments from 22 companies in 2025. Trend: 2023 $3,247 · 2024 $2,973 · 2025 $2,034
Food & beverage: $2,034
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $328 |
| PFIZER INC. | 13 | $226 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $200 |
| Alnylam Pharmaceuticals Inc. | 6 | $188 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| Amgen Inc. | 6 | $151 |
| LEO Pharma Inc. | 1 | $149 |
| Lilly USA, LLC | 5 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $89 |
| Abbott Laboratories | 5 | $85 |
Products named: Ozempic, JARDIANCE, AMVUTTRA, ANZUPGO, UPLIZNA, ELIQUIS, Kerendia, WAINUA.
Industry payments across AL — which companies pay providers there.
